Frequency of Extended-Spectrum Beta-lactamases (ESBLs) in strains of Klebsiella and E. coli isolated from patients hospitalized in Yazd
Keywords:
ESBLs, Klebsiella, E. coli, ResistanceAbstract
Introduction: Frequency of extended-spectrum beta-lactamases (ESBLs) and its variants may vary in different geographical areas, as reports indicate their spread in some certain communities. The aim of this study was to determine the frequency of ESBLs in strains of Klebsiella and E. coli, isolated from patients hospitalized in teaching hospitals of Yazd.
Methods: This cross-sectional study was carried out on samples including E. coli and Klebsiella strains collected from laboratories of Shahid Sadoughi and Shahid Rahnemoun hospitals in Yazd, Iran in the period of 2011-2012. The colonies which were positive in lactose Eosin methylene-blue (EMB) medium were identified by biochemical methods, and 270 strains of Klebsiella and E. coli were isolated. Collected data and information were analyzed using Fisher's exact test and descriptive statistics such as mean in SPSS software, version 15, at a significant level of 0.05.
Results: In this study, 270 samples were examined, including 152 samples of E. coli (56.3%) and 118 samples of Klebsiella pneumonia (43.7%). Among the 152 samples of E. coli, 45 strains (30%) were producers of ESBLs. In addition, among the 118 samples of Klebsiella pneumonia, 44 strains (37.3%) were producers of ESBLs. E. coli strains showed the most resistance to Cefotaxime (100%), Ceftazidime (97.7%), and Cefepime (75.5%) respectively and Klebsiella strains showed the most resistance to Cefotaxime (100%), Ceftazidime (100%) and Cefepime (79.5%), respectively.
Conclusion: Frequency of ESBLs in Klebsiella strains was higher than E. coli strains. No significant relationship was found between frequency of ESBLs and age or gender. In addition, E. coli strains showed the highest sensitivity to Imipenem, Amoxicillin/clavulanate, and Ciprofloxacin, while the highest antibiotic sensitivity of Klebsiella strains was shown to be to Piperacillin, Imipenem, and Amoxicillin/clavulanate.
References
Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA. Antibiotic resistance and extended spectrum betalactamases: types, epidemiology and treatment. Saudi J Biol Sci. 2015; 22(1): 90-101. doi:
1016/j.sjbs.2014.08.002. PMID: 25561890, PMCID: PMC4281622.
Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;
(4): 657-86. doi: 10.1128/CMR.18.4.657-686.2005. PMID: 16223952, PMCID: PMC1265908.
Rupp ME, Fey PD. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae:
considerations for diagnosis, prevention and drug treatment. Drugs. 2003; 63(4): 353-65. doi:
1093/cid/civ333. PMID: 12558458.
Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance
on outcomes. Clin Infect Dis. 2001; 32(8): 1162-71. doi: 10.1086/319757. PMID: 11283805.
Taha S, Youssef N, Elkazaz A, Ramadan H. Detection of extended-spectrum beta-lactamases (ESBLs) in
clinical isolates of Klebsiella pneumoniae using the ESBL NDP test and flow cytometric assay in
comparison to the standard disc diffusion. Afr J Microbiol Res. 2015; 9(34): 1947-53. doi:
5897/AJMR2015.7691.
Luvsansharav UO, Hirai I, Niki M, Sasaki T, Makimoto K, Komalamisra C, et al. Analysis of risk factors
for a high prevalence of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in
asymptomatic individuals in rural Thailand. J Med Microbiol. 2011; 60(Pt5): 619-24. doi:
1099/jmm.0.026955-0. PMID: 21292857.
Winn W, Allen S, Jandana W. Koneman's Color atlas and textbook of diagnostic microbiology, 6th edition,
Lippincott Williams and Wilkins. 2006; Appendix II.
Murray PR, Rosenthal KS, tobayashi GS, Pfaller MA. Medical Microbiology, 4th edition. Mosby Inc.
: 186.
Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and
detection of this important resistance threat. Clin Microbiol Rev. 2001; 14(4): 933-51. table of contents.
doi: 10.1128/CMR.14.4.933-951.2001. PMID: 11585791, PMCID: PMC89009.
Hosoglu S, Gundes S, Kolayli F, Karadenizli A, Demirdag K, Gunaydin M, et al. Extended-spectrum betalactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish
hospitals. Indian J Med Microbiol. 2007; 25(4): 346-50. doi: 10.4103/0255-0857.37336. PMID: 18087082.
Todar K, Todar`s online text book of bacteriology. 2011. Available From: http://www.text book of
bacteriology.net.
Navarro-Navarro M, Robles-Zepeda RE, Garibay-Escobar A, Ruiz-Bustos E. [Hospital and community- acquired beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae at hospitals in Hermosillo,
Sonora]. Salud Publica Mex. 2011; 53(4): 341-4. doi: 10.1590/S0036-36342011000400009. PMID:
Ibrahim ME, Bilal NE, Magzoub MA, Hamid ME. Prevalence of Extended-spectrum beta-Lactamases- producing Escherichia coli from Hospitals in Khartoum State, Sudan. Oman Med J. 2013; 28(2): 116-20.
doi: 10.5001/omj.2013.30. PMID: 23599880, PMCID: PMC3628198.
Eksi F, Ozer G, Balci I. [Investigation of the frequency of extended spectrum beta-lactamases and
antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp]. Mikrobiyol Bul. 2007; 41(3):
-52. PMID: 17933257.
Ozgunes I, Erben N, Kiremitci A, Kartal ED, Durmaz G, Colak H, et al. The prevalence of extended- spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk
factors. Saudi Med J. 2006; 27(5): 608-12. PMID: 16680246.
Romero ED, Padilla TP, Hernandez AH, Grande RP, Vazquez MF, Garcia IG, et al. Prevalence of clinical
isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases.
Diagn Microbiol Infect Dis. 2007; 59(4): 433-7. doi: 10.1016/j.diagmicrobio.2007.06.007. PMID:
Korten V, Ulusoy S, Zarakolu P, Mete B, Turkish MSG. Antibiotic resistance surveillance over a 4-year
period (2000-2003) in Turkey: results of the MYSTIC Program. Diagn Microbiol Infect Dis. 2007; 59(4):
-7. doi: 10.1016/j.diagmicrobio.2007.06.016. PMID: 17888609.
Ghafourian S, Bin Sekawi Z, Sadeghifard N, Mohebi R, Kumari Neela V, Maleki A, et al. The Prevalence
of ESBLs Producing Klebsiella pneumoniae Isolates in Some Major Hospitals, Iran. Open Microbiol J.
; 5: 91-5. doi: 10.2174/1874285801105010091. PMID: 21915229, PMCID: PMC3170933.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
